Christian Pellegrino
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
A fluorescein-conjugated somatostatin receptor antagonist adapter for chimeric antigen receptor T cell therapy of meningioma.
Journal: Neuro-oncology advances
Published: March 17, 2026
Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia.
Journal: Cancer research communications
Published: November 02, 2025
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance.
Journal: Journal for immunotherapy of cancer
Published: September 22, 2025
A bispecific anti-fluorescein x anti-CD3 T-cell engager in combination with fluoresceinated adaptors enables lysis of AML cells.
Journal: Molecular cancer therapeutics
Published: September 08, 2025
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells.
Journal: Molecular cancer therapeutics
Published: September 08, 2025
Immunocompetent mouse models of cancer reveal the superiority of cellular targets over stromal targets for the development of anticancer bispecific antibodies.
Journal: Molecular cancer therapeutics
Published: March 28, 2025
PSMA-Targeted Small Molecule-Drug Conjugates Based on a Postprolyl Peptidase-Cleavable Linker for the Treatment of Prostate Cancer.
Journal: Molecular cancer therapeutics
Published: August 28, 2024
An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade.
Journal: Journal for immunotherapy of cancer
Published: July 27, 2024
Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells.
Journal: Leukemia
Published: June 03, 2024
Last Updated: 09/26/2026